Regulated Information - Inventiva Pharma

Regulated Information

Regulated Information

ATM programReference Documents & Financial ReportsLiquidity ContractsNumber of Shares & Voting RightsOfferings Related Documents

2021

23rd September 2021

Inventiva completes sale of $30 million through its ATM program to existing and new specialized institutional investors

23rd September 2021

ATM Funding Program August 2, 2021 – Activation September 22, 2021

2nd August 2021

Inventiva announces the implementation of an At-The- Market program in the United Sates

2nd August 2021

2021

20th September 2021

H1 2021 Interim Financial Report

2nd August 2021

Interim condensed consolidated financial statements as at March 31, 2021

15th March 2021

Universal Registration Document (only in French)

2020

16th September 2020

H1 2020 Interim Financial Report

10th July 2020

Amendment N° 1 to URD 2019 (only in French)

10th July 2020

Security note (only in French)

19th June 2020

Universal Registration Document (only in French)

9th April 2020

2019 Annual Financial Report

10th February 2020

Universal Registration Document (only in French)

2019

25th September 2019

H1 2019 Interim Financial Report

6th May 2019

2018 Registration Document including the Annual Financial Report

2018

27th September 2018

H1 2018 Interim Financial Report

16th April 2018

2017 Registration Document including the Annual Financial Report

9th April 2018

2017 IFRS Financial Report

2017

26th September 2017

Interim Financial Report for the six months ended June 30, 2017

17th May 2017

2016 Registration Document including the Annual Financial Report

12th January 2017

Updated Document de Base (Only in french)

2016

8th July 2016

Document de base (only in french)

2021

22nd July 2021

Half-yearly review of the liquidity contract with Kepler Cheuvreux

15th January 2021

Half-yearly review of the liquidity contract with Kepler Cheuvreux

2020

12th August 2020

Half-yearly review of the liquidity contract with Kepler Cheuvreux

10th August 2020

Description of the share buyback program & resumption of the liquidity contract

14th January 2020

Half-yearly review of the liquidity contract with Kepler Cheuvreux

2019

9th July 2019

Half-yearly review of the liquidity contract with Kepler Cheuvreux

29th January 2019

Half-yearly review of the liquidity contract with Kepler Cheuvreux

2018

9th July 2018

Half-yearly review of the liquidity contract with Kepler Cheuvreux

29th May 2018

2018-2019 Share buyback programme

1st February 2018

Half yearly review and termination of liquidity contract with Oddo BHF

2017

19th July 2017

Half-yearly review of the liquidity contract with Oddo & Cie (only in French)

1st June 2017

Description of the share buyback program & Renewal of the liquidity contract

10th May 2017

Additional information regarding the liquidity contract with Oddo & Cie

23rd March 2017

Description of Inventiva’s share buyback programme for its own shares (only in French)

17th March 2017

Implementation of a Liquidity Contract with Oddo & Cie (only in French)

2021

3rd September 2021

Total voting rights and shares – August 31st, 2021

7th July 2021

Total voting rights and shares – June 30th, 2021

7th June 2021

Total voting rights and shares – May 31st, 2021

12th May 2021

Total voting rights and shares – April 30th, 2021

15th April 2021

Total voting rights and shares – March 31st, 2021

25th March 2021

Total voting rights and shares – March 10th, 2021

28th February 2021

Total Voting Rights and Share – February 28th, 2021

31st January 2021

Total Voting Rights and Share – January 31st, 2021

2020

31st December 2020

Total Voting Rights and Share – December 31st, 2020

30th November 2020

Total Voting Rights and Share – November 30th, 2020

9th November 2020

Total Voting Rights and Share – October 31st, 2020

13th October 2020

Total Voting Rights and Share – September 30th, 2020

10th September 2020

Total Voting Rights and Share – August 31st, 2020

12th May 2020

Total Voting Rights and Shares – April 30th, 2020

7th April 2020

Total Voting Rights and Shars – March 31th, 2020

4th March 2020

Total Voting Right and Shares – February 29th, 2020

14th January 2020

Total Voting Rights and Shares – December 31th, 2019

2019

13th December 2019

Total Voting Rights and Shares – November 30th, 2019

8th October 2019

Total Voting Rights and Shares – September 30th, 2019

5th September 2019

Total Voting Rights and Shares – August 31th, 2019

Investor Contacts

Inventiva
50 rue de Dijon
21121 Daix, France
Email: finance@inventivapharma.com
Tel: +33 (0)3 80 44 75 00

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com

Regulated Information